Detalles de la búsqueda
1.
A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease.
Br J Clin Pharmacol
; 75(5): 1231-9, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23116458
2.
Haloperidol-induced hypokinesia in rats is differentially affected by the light/dark phase, age, and melatonin.
Behav Brain Res
; 379: 112313, 2020 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31715211
3.
Procrastination, Flow, and Academic Performance in Real Time Using the Experience Sampling Method.
J Genet Psychol
; 179(3): 123-131, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29595377
4.
Differential effects of a short-term high-fat diet in an animal model of depression in rats treated with the 5-HT3 receptor antagonist, ondansetron, the 5-HT3 receptor agonist, 2-methyl-5-HT, and the SSRI, fluoxetine.
Pharmacol Biochem Behav
; 144: 78-84, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26979154
5.
Methanesulfonyl fluoride, an acetylcholinesterase inhibitor, attenuates simple learning and memory deficits in ischemic rats.
Brain Res
; 1038(1): 50-8, 2005 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15748872
6.
Prenatal exposure to the acetylcholinesterase inhibitor methanesulfonyl fluoride alters forebrain morphology and gene expression.
Brain Res Dev Brain Res
; 158(1-2): 13-22, 2005 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-15964079
7.
Behavioral characterization and modulation of circadian rhythms by light and melatonin in C3H/HeN mice homozygous for the RORbeta knockout.
Am J Physiol Regul Integr Comp Physiol
; 292(6): R2357-67, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17303680
Resultados
1 -
7
de 7
1
Próxima >
>>